Celcuity Inc
CELCHealthcare|Biotechnology|USA
$107.58
-5.93 (-5.22%)
Tangible Book
$1.11
Earnings Power
$1.12
Financials
Financial Snapshot
Market Cap
$5.25B
Enterprise Value
$63.6M
Revenue (TTM)
$0.00
Net Income (TTM)
$-192.9M
Cash & Equivalents
—
Net Cash/Share
$0.63
Free Cash Flow (TTM)
$-173.0M
Operating CF (TTM)
$-172.5M
Debt/Equity
6.04
Cash Runway & Burn Rate
Cash on Hand
$0.00
Quarterly Burn
$43.1M
Monthly Burn
$14.4M
Est. Runway
—
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Investments | $5.9M | $24.2M | $24.9M | $18.7M | $11.6M | $84.3M | $168.6M | $180.6M | $235.1M | $441.5M | $387.1M | |
| Operating Cash Flow | $-2.9M | $-4.9M | $-6.1M | $-6.0M | $-7.1M | $-20.3M | $-36.0M | $-53.8M | $-83.5M | $-153.3M | $-172.5M | |
| Free Cash Flow | $-2.9M | $-5.2M | $-6.7M | $-6.4M | $-7.2M | $-20.4M | $-36.2M | $-53.9M | $-83.7M | $-153.5M | $-173.0M | |
| Capital Expenditure | $-41.0K | $-240.0K | $-630.0K | $-380.0K | $-89.0K | $-82.0K | $-159.0K | $-98.0K | $-250.0K | $-249.0K | $-474.0K | |
| Financing Cash Flow | $3.7M | $30.7M | $237.0K | $259.0K | $138.0K | $93.0M | $120.3M | $64.9M | $138.4M | $360.6M | $355.0M |
R&D Spending
R&D (TTM)
$145.8M
R&D Intensity
—
R&D Growth YoY
+0.6%
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| R&D Expense | $3.1M | $5.0M | $6.3M | $6.3M | $7.7M | $25.8M | $35.3M | $60.6M | $104.2M | $145.0M | $145.8M | |
| R&D % of Revenue | — | — | — | — | — | — | — | — | — | — | — | |
| SG&A | $264.0K | $973.0K | $1.6M | $1.5M | $1.9M | $2.6M | $4.1M | $5.6M | $9.1M | $27.2M | $40.7M |
Income Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Cost of Goods Sold | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| R&D | $3.1M | $5.0M | $6.3M | $6.3M | $7.7M | $25.8M | $35.3M | $60.6M | $104.2M | $145.0M | $145.8M | |
| SG&A | $264.0K | $973.0K | $1.6M | $1.5M | $1.9M | $2.6M | $4.1M | $5.6M | $9.1M | $27.2M | $40.7M | |
| Operating Income | $-3.3M | $-6.0M | $-7.9M | $-7.8M | $-9.6M | $-28.4M | $-39.4M | $-66.2M | $-113.3M | $-172.2M | $-186.6M | |
| Interest Expense | $0.00 | $-452.0K | $0.00 | $0.00 | $0.00 | $-1.3M | $-2.1M | $-5.3M | $-10.3M | $-17.1M | $-20.1M | |
| Pretax Income | $-3.3M | $-6.3M | $-7.5M | $-7.4M | $-9.5M | $-29.6M | $-40.4M | $-63.8M | $-111.8M | $-177.0M | $-192.9M | |
| Net Income | $-3.3M | $-6.3M | $-7.5M | $-7.4M | $-9.5M | $-29.6M | $-40.4M | $-63.8M | $-111.8M | $-177.0M | $-192.9M | |
| EPS (Diluted) | -0.49 | -0.84 | -0.74 | -0.72 | -0.92 | -2.21 | -2.64 | -2.69 | -2.83 | -3.79 | -3.90 | |
| EBITDA | $-3.2M | $-5.7M | $-7.3M | $-7.0M | $-9.1M | $-28.0M | $-38.1M | $-58.3M | $-101.4M | $-159.7M | $-172.7M | |
| Shares Out. (M) | 6.72 | 7.46 | 10.13 | 10.23 | 10.27 | 13.38 | 15.42 | 23.68 | 39.45 | 46.76 | 54.46 |
Balance Sheet
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.9M | $2.6M | $15.9M | $18.7M | $11.6M | $84.3M | $24.6M | $30.7M | $22.5M | $165.7M | $145.2M | |
| Marketable Securities | $0.00 | $21.6M | $9.0M | $0.00 | $0.00 | $0.00 | $144.0M | $149.9M | $212.6M | $275.8M | $241.9M | |
| Total Current Assets | $5.9M | $24.5M | $25.2M | $19.3M | $12.2M | $85.4M | $175.2M | $190.6M | $244.6M | $465.7M | $408.9M | |
| Total Assets | $6.1M | $32.0M | $26.0M | $20.3M | $13.0M | $85.9M | $175.7M | $191.2M | $245.1M | $466.6M | $410.2M | |
| Total Current Liabilities | $445.0K | $578.0K | $662.0K | $911.0K | $1.2M | $2.5M | $6.9M | $14.2M | $31.7M | $44.2M | $33.2M | |
| Long-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $14.6M | $35.0M | $37.0M | $97.7M | $321.9M | $323.4M | |
| Total Liabilities | $445.0K | $578.0K | $682.0K | $983.0K | $1.3M | $17.2M | $41.9M | $51.5M | $129.5M | $366.0M | $356.6M | |
| Stockholders' Equity | $5.6M | $31.4M | $25.4M | $19.3M | $11.7M | $68.7M | $133.8M | $139.8M | $115.6M | $100.6M | $53.5M | |
| Retained Earnings | $-8.3M | $-2.0M | $-9.5M | $-16.8M | $-26.3M | $-55.9M | $-96.3M | $-160.1M | $-271.9M | $-448.9M | $-501.7M |
Cash Flow Statement
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-2.9M | $-4.9M | $-6.1M | $-6.0M | $-7.1M | $-20.3M | $-36.0M | $-53.8M | $-83.5M | $-153.3M | $-172.5M | |
| Capital Expenditure | $-41.0K | $-240.0K | $-630.0K | $-380.0K | $-89.0K | $-82.0K | $-159.0K | $-98.0K | $-250.0K | $-249.0K | $-474.0K | |
| Free Cash Flow | $-2.9M | $-5.2M | $-6.7M | $-6.4M | $-7.2M | $-20.4M | $-36.2M | $-53.9M | $-83.7M | $-153.5M | $-173.0M | |
| Investing Cash Flow | $-41.0K | $-29.0M | $19.1M | $8.5M | $-89.0K | $-81.0K | $-144.0M | $-5.0M | $-63.1M | $-64.1M | $-53.8M | |
| Financing Cash Flow | $3.7M | $30.7M | $237.0K | $259.0K | $138.0K | $93.0M | $120.3M | $64.9M | $138.4M | $360.6M | $355.0M | |
| Issuance of Stock | $3.7M | $24.1M | $0.00 | $0.00 | $183.0K | $78.6M | $100.5M | $14.4M | $63.6M | $91.6M | $91.6M | |
| Repurchase of Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Issuance of Debt | $0.00 | $7.5M | $0.00 | $0.00 | $0.00 | $14.3M | $19.5M | $0.00 | $59.2M | $222.7M | $222.7M | |
| Payments of Debt | $0.00 | $0.00 | $-3.0K | $-6.0K | $-6.0K | $-6.0K | $-6.0K | $-2.0K | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $187.0K | $874.0K | $1.2M | $1.0M | $1.8M | $2.6M | $4.6M | $4.9M | $7.0M | $21.4M | $24.3M | |
| Net Change in Cash | $789.0K | $-3.2M | $13.3M | $2.8M | $-7.1M | $72.6M | $-59.7M | $6.1M | $-8.1M | $143.2M | $128.7M |
Dilution Tracker
Shares outstanding grew 307.0% over 5 years — significant dilution
Shares Outstanding
54M
5-Year Share Growth
+307.0%
Stock Issuance (TTM)
$91.6M
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Out. (M) | 6.72 | 7.46 | 10.13 | 10.23 | 10.27 | 13.38 | 15.42 | 23.68 | 39.45 | 46.76 | 54.46 | |
| YoY Change % | — | 11.1% | 35.7% | 1.0% | 0.4% | 30.3% | 15.2% | 53.6% | 66.6% | 18.5% | 16.5% | |
| Stock Issuance | $3.7M | $24.1M | $0.00 | $0.00 | $183.0K | $78.6M | $100.5M | $14.4M | $63.6M | $91.6M | $91.6M | |
| Stock Repurchase | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $187.0K | $874.0K | $1.2M | $1.0M | $1.8M | $2.6M | $4.6M | $4.9M | $7.0M | $21.4M | $24.3M |
Margins & Profitability
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | - | |
| Net Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | - | |
| EBITDA Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | - | |
| FCF Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| ROE % | -62.3% | -33.8% | -26.4% | -33.0% | -61.1% | -73.6% | -39.9% | -46.6% | -87.5% | -163.8% | -239.9% | |
| ROA % | -58.3% | -32.9% | -25.8% | -31.8% | -57.0% | -59.9% | -30.9% | -34.8% | -51.2% | -49.8% | -55.0% | |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - | - |
Valuation
P/E (TTM)At Loss
HistoricalAt Loss / At Loss / At Loss
Industry Med.27.51
P/S—
Historical— / — / —
Industry Med.9.49
P/B97.18
Historical— / — / 97.18
Industry Med.2.93
EV/EBITDA-30.02
Historical-30.02 / — / —
Industry Med.13.02
EV/Revenue—
Historical— / — / —
Industry Med.8.59
P/FCF—
Historical— / — / —
Industry Med.27.13
Intrinsic Value Models
Tangible Book
$1.11
Net Current Assets
$1.080
Net-Net Working Capital
$0.63
| Metric | Trend | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PE Ratio | N/A | At Loss | At Loss | At Loss | At Loss | At Loss | At Loss | At Loss | At Loss | At Loss | At Loss | |
| PS Ratio | - | - | - | - | - | - | - | - | - | - | 0.00 | |
| PB Ratio | 0.00 | 6.09 | 9.64 | 5.65 | 8.06 | 2.86 | 2.27 | 2.66 | 4.20 | 47.86 | 97.18 | |
| EV/EBITDA | 0.00 | -29.32 | -30.24 | -12.91 | -9.13 | -4.54 | -4.47 | -3.92 | -3.44 | -29.38 | -30.02 | |
| EV/Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analyst Estimates & Quality
Altman Z-Score
—
Distress
Piotroski F-Score
2
Weak
Beneish M-Score
—
Possible Manipulator
Forward Estimates
| Metric | Current Year | Next Year | 2 Years Out |
|---|---|---|---|
| Revenue | $42.08M | $408.28M | $763.20M |
| Net Income | $-217.33M | $-15.59M | $215.34M |
| EPS | -4.02 | -0.77 | 3.43 |
| Book Value per Share | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow per Share | 0.00 | 0.00 | 0.00 |
| Operating CF | $0.00M | $0.00M | $0.00M |